Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kishimoto

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Circulation|March 1, 1988
Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral bloodC Kishimoto, T Misaki, C S Crumpacker, et al.
Journal of the American College of Cardiology|June 1, 1984
Electrocardiographic findings in experimental myocarditis in DBA/2 mice: complete atrioventricular block in the acute stage, low voltage of the QRS complex in the subacute stage and arrhythmias in the chronic stageC Kishimoto, A Matsumori, M Ohmae, et al.
Journal of Molecular and Cellular Cardiology|April 11, 2000
Role of MIP-2 in coxsackievirus B3 myocarditisC Kishimoto, H Kawamata, S Sakai, et al.
Heart and Vessels|July 27, 2001
A nuclear complex containing PPARalpha/RXRalpha is markedly downregulated in the hypertrophied rat left ventricular myocardium with normal systolic functionH Kanda, R Nohara, K Hasegawa, et al.
Journal of Cardiography. Supplement|January 1, 1986
[Immunological background of patients with dilated cardiomyopathy and myocarditis: clinical and experimental studies]C Kishimoto, A Matsumori, N Tomioka, et al.
Plos One|November 21, 2022
Muscle electromyographic activity normalized to maximal muscle activity, not to Mmax, better represents voluntary activationJoanna Diong, Kenzo C Kishimoto, Jane E Butler, et al.
American Heart Journal|July 1, 1985
Improved evaluation of hypertrophic cardiomyopathy by biventriculography with axial projectionC Kishimoto, K Kadota, T Sakurai, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 20, 2010
Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide productionK Shimada, T Murayama, M Yokode, et al.
Japanese Circulation Journal|June 16, 2001
Serum thioredoxin (TRX) levels in patients with heart failureC Kishimoto, K Shioji, H Nakamura, et al.
Japanese Circulation Journal|December 1, 1986
The in vivo cardiotoxic effect of eosinophilic cationic protein in an animal preparationC Kishimoto, C J Spry, P C Tai, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Circulation|March 1, 1988
Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral bloodC Kishimoto, T Misaki, C S Crumpacker, et al.
Journal of the American College of Cardiology|June 1, 1984
Electrocardiographic findings in experimental myocarditis in DBA/2 mice: complete atrioventricular block in the acute stage, low voltage of the QRS complex in the subacute stage and arrhythmias in the chronic stageC Kishimoto, A Matsumori, M Ohmae, et al.
Journal of Molecular and Cellular Cardiology|April 11, 2000
Role of MIP-2 in coxsackievirus B3 myocarditisC Kishimoto, H Kawamata, S Sakai, et al.
Heart and Vessels|July 27, 2001
A nuclear complex containing PPARalpha/RXRalpha is markedly downregulated in the hypertrophied rat left ventricular myocardium with normal systolic functionH Kanda, R Nohara, K Hasegawa, et al.
Journal of Cardiography. Supplement|January 1, 1986
[Immunological background of patients with dilated cardiomyopathy and myocarditis: clinical and experimental studies]C Kishimoto, A Matsumori, N Tomioka, et al.
Plos One|November 21, 2022
Muscle electromyographic activity normalized to maximal muscle activity, not to Mmax, better represents voluntary activationJoanna Diong, Kenzo C Kishimoto, Jane E Butler, et al.
American Heart Journal|July 1, 1985
Improved evaluation of hypertrophic cardiomyopathy by biventriculography with axial projectionC Kishimoto, K Kadota, T Sakurai, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 20, 2010
Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide productionK Shimada, T Murayama, M Yokode, et al.
Japanese Circulation Journal|June 16, 2001
Serum thioredoxin (TRX) levels in patients with heart failureC Kishimoto, K Shioji, H Nakamura, et al.
Japanese Circulation Journal|December 1, 1986
The in vivo cardiotoxic effect of eosinophilic cationic protein in an animal preparationC Kishimoto, C J Spry, P C Tai, et al.
Pageof 8